Work

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's disease

Year: 1998

Type: article

Source: Clinical Therapeutics

DOI: 10.1016/s0149-2918(98)80127-6

Author: Ronald J. Polinsky

Institution: Novartis (United States)

Language: English

Topic: Cholinesterase and Neurodegenerative Diseases

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2093345349

FWCI: 6.01

Cites: 24

Cited by: 332

Related to: 10